SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-18-004481
Filing Date
2018-07-02
Accepted
2018-07-02 17:01:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7933010_13-g.htm SC 13G 71119
  Complete submission text file 0000919574-18-004481.txt   72646
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88910 | Film No.: 18933548
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G